A detailed history of Advisors Asset Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 689,185 shares of PFE stock, worth $18.4 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
689,185
Previous 660,481 4.35%
Holding current value
$18.4 Million
Previous $18.5 Million 7.93%
% of portfolio
0.38%
Previous 0.37%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$27.7 - $31.39 $795,100 - $901,018
28,704 Added 4.35%
689,185 $19.9 Million
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $114,781 - $134,502
4,544 Added 0.69%
660,481 $18.5 Million
Q1 2024

May 14, 2024

BUY
$25.89 - $29.73 $2.03 Million - $2.33 Million
78,352 Added 13.57%
655,937 $18.2 Million
Q4 2023

Feb 14, 2024

BUY
$26.13 - $33.94 $745,096 - $967,799
28,515 Added 5.19%
577,585 $16.6 Million
Q2 2023

Aug 14, 2023

BUY
$36.12 - $41.79 $921,854 - $1.07 Million
25,522 Added 4.87%
549,070 $20.1 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $418,439 - $544,747
-10,623 Reduced 1.99%
523,548 $21.4 Million
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $698,185 - $911,403
16,723 Added 3.23%
534,171 $27.4 Million
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $947,316 - $1.16 Million
-21,648 Reduced 4.02%
517,448 $22.6 Million
Q2 2022

Aug 08, 2022

SELL
$46.53 - $55.17 $1.26 Million - $1.49 Million
-27,082 Reduced 4.78%
539,096 $28.3 Million
Q1 2022

May 17, 2022

BUY
$45.75 - $56.69 $241,971 - $299,833
5,289 Added 0.94%
566,178 $29.3 Million
Q4 2021

Feb 15, 2022

SELL
$41.32 - $61.25 $836,234 - $1.24 Million
-20,238 Reduced 3.48%
560,889 $33.1 Million
Q3 2021

Nov 12, 2021

SELL
$39.25 - $50.42 $3.47 Million - $4.46 Million
-88,404 Reduced 13.2%
581,127 $25 Million
Q2 2021

Jul 30, 2021

SELL
$35.91 - $40.68 $5.46 Million - $6.18 Million
-151,995 Reduced 18.5%
669,531 $26.2 Million
Q1 2021

May 07, 2021

SELL
$33.49 - $37.77 $3.49 Million - $3.94 Million
-104,357 Reduced 11.27%
821,526 $29.8 Million
Q4 2020

Feb 12, 2021

SELL
$33.47 - $42.56 $6.06 Million - $7.7 Million
-181,022 Reduced 16.35%
925,883 $34.1 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $1.96 Million - $2.3 Million
-61,636 Reduced 5.27%
1,106,905 $40.6 Million
Q2 2020

Aug 12, 2020

BUY
$30.12 - $36.54 $674,868 - $818,715
22,406 Added 1.95%
1,168,541 $38.2 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $2.46 Million - $3.51 Million
90,972 Added 8.62%
1,146,135 $37.4 Million
Q4 2019

Feb 14, 2020

BUY
$32.92 - $37.36 $185,175 - $210,150
5,625 Added 0.54%
1,055,163 $41.3 Million
Q3 2019

Nov 14, 2019

SELL
$32.49 - $42.13 $2.84 Million - $3.68 Million
-87,465 Reduced 7.69%
1,049,538 $37.7 Million
Q2 2019

Aug 14, 2019

SELL
$36.98 - $41.52 $4.83 Million - $5.42 Million
-130,629 Reduced 10.3%
1,137,003 $49.3 Million
Q1 2019

May 15, 2019

SELL
$37.5 - $41.2 $5.45 Million - $5.99 Million
-145,393 Reduced 10.29%
1,267,632 $53.8 Million
Q4 2018

Jan 31, 2019

SELL
$38.47 - $43.86 $7.55 Million - $8.61 Million
-196,252 Reduced 12.2%
1,413,025 $61.7 Million
Q3 2018

Nov 15, 2018

SELL
$34.47 - $41.81 $1.11 Million - $1.35 Million
-32,310 Reduced 1.97%
1,609,277 $70.9 Million
Q2 2018

Aug 22, 2018

BUY
$32.98 - $35.16 $45.4 Million - $48.4 Million
1,376,035 Added 518.18%
1,641,587 $59.6 Million
Q2 2018

Aug 15, 2018

SELL
$32.98 - $35.16 $49.2 Million - $52.5 Million
-1,493,241 Reduced 84.9%
265,552 $59.6 Million
Q1 2018

May 15, 2018

SELL
$31.91 - $37.02 $566,881 - $657,660
-17,765 Reduced 1.0%
1,758,793 $63.9 Million
Q4 2017

Feb 13, 2018

SELL
$33.26 - $35.29 $1.36 Million - $1.45 Million
-40,990 Reduced 2.26%
1,776,558 $64.3 Million
Q3 2017

Nov 07, 2017

BUY
$31.0 - $34.15 $56.3 Million - $62.1 Million
1,817,548
1,817,548 $64.9 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.